IEEE

Optimal combination between subjective weighting and objective weighting based on maximum square sum of distance for information security risk assessment

Abstract: In this paper, it is shown a new comprehensive weighting to compute the weights of risk factors in information security risk assessment. firstly, the principal eigenvector is the ...
Pharmabiz

Hutchmed begins phase III stage of the ongoing trial of the combination of surufatinib and camrelizumab to treat naïve pancreatic ductal adenocarcinoma

Hutchmed (China) Limited (Hutchmed), an innovative, commercial-stage, biopharmaceutical company, announces that it has initiated the phase III part of the phase II/III trial to evaluate the efficacy ...
Aktien Check

HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that it has initiated the Phase III ...
Investing

Texas Ventures Acquisition III Corp to pay advisory fee to CEO during business combination process

Texas Ventures Acquisition III Corp (NASDAQ:TVACU, NASDAQ:TVA, NASDAQ:TVACW) disclosed Tuesday that its board of directors approved a monthly advisory fee of $15,000 for Chief Executive Officer Kevin ...
Investing

Texas Ventures Acquisition III Corp to pay advisory fee to CEO during business combination process

According to the SEC filing, the advisory fee is effective as of October 2025 and will continue on a monthly basis until the earlier of the completion of the company’s initial business combination or ...